Business Context and Reporting Period
This Form 8-K filing by IMMUNIC, INC. (IMUX) reports a corporate governance event dated January 5, 2026. The Company, incorporated in Delaware and headquartered in New York, NY, operates on the Nasdaq Stock Market. The filing addresses a change in the listing status of its common stock.
Key Financial Metrics
This filing is a current report regarding listing status and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes Versus Prior Period
- Listing Transfer Approved: Nasdaq approved the transfer of IMUX common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective at the opening of business on January 7, 2026.
- Compliance Status: The transfer was necessitated because the Company failed to regain compliance with Nasdaq Listing Rule 5450(a)(1) (the "Bid Price Rule") by the December 24, 2025 deadline. The stock had closed below $1.00 for 30 consecutive business days.
- Trading Symbol: The stock will continue to trade under the symbol "IMUX."
Guidance, Outlook, Risks, and Contingencies
- New Compliance Deadline: The Company has been granted an additional 180-day grace period to regain compliance, extending until June 22, 2026.
- Compliance Requirement: To maintain listing on the Nasdaq Capital Market, the minimum bid price per share must be at least $1.00 for at least 10 consecutive business days on or prior to June 22, 2026.
- Reverse Stock Split: As a condition of the approval, the Company notified Nasdaq of its intent to implement a reverse stock split if necessary to meet the bid price requirement.
- Delisting Risk: If the Company fails to regain compliance by the new deadline, Nasdaq will determine to delist the stock. The Company would have the opportunity to appeal to a Nasdaq Listing Qualifications Panel, though there is no assurance of success.
Important Facts for Investor Verification
- Verify the effective date of the listing transfer (January 7, 2026) and confirm trading continues under the symbol IMUX.
- Monitor the stock price to ensure it meets the $1.00 threshold for 10 consecutive days before the June 22, 2026 deadline.
- Watch for future announcements regarding the potential implementation of a reverse stock split.
- Review the Company's financial health in upcoming periodic reports (10-Q/10-K) as this 8-K does not contain financial data.